First Horizon Advisors Inc. Decreases Stock Holdings in ARK Genomic Revolution ETF (BATS:ARKG)

First Horizon Advisors Inc. reduced its position in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 11.7% in the third quarter, according to its most recent filing with the SEC. The fund owned 4,104 shares of the company’s stock after selling 546 shares during the quarter. First Horizon Advisors Inc.’s holdings in ARK Genomic Revolution ETF were worth $105,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Main Management ETF Advisors LLC lifted its position in ARK Genomic Revolution ETF by 2.3% during the second quarter. Main Management ETF Advisors LLC now owns 2,754,610 shares of the company’s stock valued at $64,678,000 after purchasing an additional 62,470 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of ARK Genomic Revolution ETF by 2.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 166,281 shares of the company’s stock valued at $3,904,000 after acquiring an additional 3,341 shares during the last quarter. Cetera Investment Advisers grew its position in ARK Genomic Revolution ETF by 290.7% in the first quarter. Cetera Investment Advisers now owns 140,897 shares of the company’s stock worth $4,052,000 after acquiring an additional 104,831 shares in the last quarter. Prudential PLC increased its stake in ARK Genomic Revolution ETF by 15.0% during the second quarter. Prudential PLC now owns 140,170 shares of the company’s stock worth $3,326,000 after acquiring an additional 18,300 shares during the last quarter. Finally, SG Americas Securities LLC raised its position in ARK Genomic Revolution ETF by 5.4% during the second quarter. SG Americas Securities LLC now owns 129,356 shares of the company’s stock valued at $3,037,000 after purchasing an additional 6,675 shares during the period.

ARK Genomic Revolution ETF Price Performance

BATS:ARKG opened at $23.83 on Friday. The company has a 50-day moving average of $24.69 and a 200 day moving average of $25.11.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.